drugset / Trial / NCT07862712

Assessing Trauma-related Links Between Affective and Metabolic Systems

NCT07862712 ↗

Phase 4 Not yet recruiting 70 enrolled VA Office of Research and Development
NaSingle-groupOpen-labelTreatment

Summary

KEY INFORMATION: The purpose of this study is to understand how insulin resistance (how your body processes sugar) and PTSD might be related. The goal is to improve the health of Veterans in three ways: 1. Understanding health risks: The investigators want to learn why Veterans with post-traumatic stress disorder (PTSD) are more likely to develop medical problems related to insulin resistance, such as diabetes. 2. Testing effects of a medication: The investigators are testing whether prazosin, a medication that studies have shown may address some PTSD symptoms, can also improve how the body responds to insulin. If it does, this could point to a specific biological pathway that could be targeted for development of new treatments to prevent insulin resistance and diabetes in Veterans with PTSD. 3. Links to depression. The investigators will also look at whether insulin sensitivity affects depression symptoms in people with PTSD. This may inform future research into treatments for PTSD.

Timeline

Start
2027-03-01
Primary completion
2031-12-31
Completion
2032-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown — —